Matinas Biopharma Holdings, Inc.

The current price of MTNB is 0.1900 USD — it has decreased by 1.04% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Matinas Biopharma Holdings, Inc. stocks are traded under the ticker MTNB.

Matinas Biopharma Holdings, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.

MTNB stock is 9.98% volatile and has beta coefficient of 1.00. Check out the list of the most volatile stocks — is Matinas Biopharma Holdings, Inc. there?

One year price forecast for Matinas Biopharma Holdings, Inc. has a max estimate of 1.0000 USD and a min estimate of 1.0000 USD.

MTNB earnings for the last quarter are −0.03 USD whereas the estimation was −0.03 USD which accounts for −3.27% surprise. Estimated earnings for the next quarter are −0.03 USD. See more details about Matinas Biopharma Holdings, Inc. earnings.

Matinas Biopharma Holdings, Inc. revenue for the last quarter amounts to ‪1.10 M‬ USD despite the estimated figure of ‪300.00 K‬ USD. In the next quarter revenue is expected to reach ‪300.00 K‬ USD.

Yes, you can track Matinas Biopharma Holdings, Inc. financials in yearly and quarterly reports right on TradingView.

MTNB net income for the last quarter is ‪−5.31 M‬ USD, while the quarter before that showed ‪−6.06 M‬ USD of net income which accounts for 12.24% change. Track more Matinas Biopharma Holdings, Inc. financial stats to get the full picture.

Today Matinas Biopharma Holdings, Inc. has the market capitalization of ‪47.66 M‬, it has decreased by 31.13% over the last week.

No, MTNB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, MTNB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Matinas Biopharma Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.

MTNB reached its all-time high on Mar 2, 2017 with the price of 3.9900 USD, and its all-time low was 0.1103 USD and was reached on Aug 10, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 32.00 employees. See our rating of the largest employees — is Matinas Biopharma Holdings, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Matinas Biopharma Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Matinas Biopharma Holdings, Inc. stock shows the strong sell signal. See more of Matinas Biopharma Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Matinas Biopharma Holdings, Inc. future price: according to them, MTNB price has a max estimate of 1.00 USD and a min estimate of 1.00 USD. Read a more detailed Matinas Biopharma Holdings, Inc. forecast: see what analysts think of Matinas Biopharma Holdings, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Matinas Biopharma Holdings, Inc. EBITDA is ‪−22.83 M‬ USD, and current EBITDA margin is ‪−2.08 K‬%. See more stats in Matinas Biopharma Holdings, Inc. financial statements.